Successful one stage operation for a synchronous, duodenal carcinoma, colonic carcinoma and renal oncocytoma in an adult patient

World Journal of Surgical Oncology

Mohamed Khalife¹  Ali Shamseddine¹  Ashraf Shamseddine¹  Deborah Mukherji¹  Eman Sbaity¹  Walid Faraj¹ 

[1] American University of Beirut, Medical Centre Department of Surgery, HPB and Liver Transplant Unit, Beirut, Lebanon

关键词: synchronous tumors;    pancreaticoduodenectomy;    oncocytoma;    duodenal cancer;    Colon cancer;   

Others  :  1206665
DOI  :  10.1186/1477-7819-9-99

 received in 2011-05-13, accepted in 2011-09-01,  发布年份 2011

【 摘 要 】

We report a rare case of synchronous duodenal carcinoma, colonic carcinoma and renal oncocytoma successfully treated using a one-stage surgical approach. Potential risk factors for multiple primary malignancies associated with duodenal carcinoma are discussed. This case illustrates several practice points for consideration: 1. Patients presenting with small intestinal carcinomas have a higher than average chance of developing second primary tumors in other organs; this should be taken into consideration during staging and follow-up. 2. For full staging of patients presenting with small bowel tumors, upper and lower gastrointestinal endoscopy and PET scanning should be considered. 3. A one-stage surgical procedure can be used safely and successfully for multiple synchronous primary tumors.

【 授权许可】

   
2011 Faraj et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Neugut AI, et al.: The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 1998, 7:243-251.
• [2]Jarvinen HJ, Nyberg M, Peltokallio P: Biliary involvement in familial adenomatosis coli. Dis Colon Rectum 1983, 26:525-528.
• [3]Scelo G, et al.: Associations between small intestine cancer and other primary cancers: an international population-based study. Int J Cancer 2006, 118:189-196.
• [4]Whelan SL: Cancer Incidence in Five Continents. Coding practices. IARC Sci Publ 1992, 31-38.
• [5]Chow JS, et al.: A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Int J Epidemiol 1996, 25:722-728.
• [6]Dabaja BS, et al.: Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 2004, 101:518-526.
• [7]Warren S, G O: Multiple primary malignant tumors. A survery of the literature and a statistical study. Am J Cancer 1932, 16:1358-1414.
• [8]Persson PG, et al.: Crohn's disease and cancer: a population-based cohort study. Gastroenterology 1994, 107:1675-1679.
• [9]Neugut AI, Santos J: The association between cancers of the small and large bowel. Cancer Epidemiol Biomarkers Prev 1993, 2:551-553.
• [10]Bjork J, et al.: Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 2001, 121:1127-1135.
• [11]Mecklin JP, Jarvinen HJ, Virolainen M: The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma. Cancer 1992, 69:1112-1114.
• [12]Minni F, et al.: Second tumours in patients with malignant neoplasms of the digestive apparatus. A retrospective study on 2406 cases. Ann Ital Chir 2005, 76:467-472.
• [13]Alamara C, et al.: Renal oncocytoma: a case report and short review of the literature. Eur J Intern Med 2008, 19:e67-69.
• [14]Chao DH, et al.: Changing concepts in the management of renal oncocytoma. Urology 2002, 59:635-42.
• [15]Katani I, et al.: Sequential FDG-PET/CT as a biomarker of response to sunitinib in metastatic clear cell renal cancer. Clin Cancer Res 2011.